EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 24.6% of their position (31.25K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $5.1K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/23/2026ACC: 0001493152-26-048196
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+31.25K
Net shares
Net buyer
$5.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
31.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+31.25K
Price / share
$0.16
Trade value
$5.09K
% of position
24.6%
10/22/2026
126.82K→158.07K
Total
Net shares
+31.25K
Net value
$5.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/22/2026 | P · Purchase | +31.25K | $0.16 | $5.09K | 24.6% | 126.82K | 158.07K |
| Total | +31.25K | $5.09K | ||||||
Derivative Transactions0
No derivative transactions reported